Does adding the Generalised Anxiety Disorder (GAD) questionnaire and Patient Health Questionnaire-9 (PHQ-9) to routine outpatient activity provide more information on the presence of anxiety and depression in asthma?

K. Barber (Liverpool, United Kingdom), R. Robinson (Liverpool, United Kingdom), J. Blakey (Liverpool, United Kingdom)

Source: International Congress 2018 – Asthma: clinical screening tools

Session: Asthma: clinical screening tools
Session type: Thematic Poster
Number: 683

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Barber (Liverpool, United Kingdom), R. Robinson (Liverpool, United Kingdom), J. Blakey (Liverpool, United Kingdom). Does adding the Generalised Anxiety Disorder (GAD) questionnaire and Patient Health Questionnaire-9 (PHQ-9) to routine outpatient activity provide more information on the presence of anxiety and depression in asthma?. 683

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Comparison of diagnostic value of patient health questionnaire 9 (PHQ-9) and Beck depression inventory (BDI) questionnaire for preliminary diagnosing of depression in COPD patients (pts) Source: International Congress 2014 – COPD markers Year: 2014
Impact of symptoms of anxiety and depression on COPD Assessment Test scores Source: Eur Respir J 2014; 43: 898-900 Year: 2014
Beck depression inventory-II: Determination and comparison of its diagnostic accuracy in asthmatic outpatients Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013
Anxiety and depression in patients with asthma Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control Year: 2011
Anxiety and depression in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 275s Year: 2005
Anxiety and depression in patients with asthma Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010
Relationship between Hospital Anxiety and Depresion Scale (HADS) and clinical asthma control Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010
2 days at the sea-side! Effects on anxiety and depression scores, Health Locus of Control (HLOC) and Patient’s Global Impression of Change (PGIC) in COPD patients. Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects Year: 2018
Satisfaction with asthma treatment questionnaire, (SATQ) Source: Eur Respir J 2002; 20: Suppl. 38, 203s Year: 2002
Depression in chronic obstructive pulmonary disease: Predictors and accuracy of the hospital anxiety and depression scale (HADS) Source: International Congress 2014 – Latest insights in chronic care Year: 2014
Management of depression and anxiety in COPD Source: Eur Respir Mon 2013; 59: 144-163 Year: 2013
Validity and reliability of the Stanford Brief Activity Survey (SBAS) in patients with COPD Source: Annual Congress 2010 - Outcomes in chronic lung disease: assessing the value of interventions – physical activity, strength and exercise Year: 2010
Depression and anxiety in patients with COPD Source: Eur Respir Rev 2014; 23: 345-349 Year: 2014
Psychological comorbidity (depression and anxiety) in children with asthma Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
Predictors of E-Cigarette Use: Smoking and Self-Identified Depression and/or Anxiety Source: International Congress 2019 – From the health effects of tobacco to the epidemiology of tobacco/electronic nicotine delivery system use Year: 2019
Health-related quality of life in COPD: why both disease-specific and generic measures should be used Source: Eur Respir J 2001; 18: 69-76 Year: 2001
Development of the morning activities and symptoms questionnaire (MASQ) for COPD Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008
Development and validation of the REspiratory Symptom in Preschool children Questionnaire (RESPQ) Source: Eur Respir J 2005; 26: Suppl. 49, 478s Year: 2005
The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID) Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019
Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL) Source: Eur Respir J 2001; 17: 52-58 Year: 2001